Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Drug Metabolism & Disposition
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Drug Metabolism & Disposition

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit dmd on Facebook
  • Follow dmd on Twitter
  • Follow ASPET on LinkedIn

Index by author

July 01, 2005; Volume 33,Issue 7
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

A

  1. Adelsberger, Jennifer

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  2. Annaert, Pieter

    1. You have access
      EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046

B

  1. Baillie, Thomas A.

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  2. Barama, Azemi

    1. You have access
      CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS
      Jean-Nicholas Roy, Julie Lajoie, Lynn S. Zijenah, Azemi Barama, Charles Poirier, Brian J. Ward and Michel Roger
      Drug Metabolism and Disposition July 2005, 33 (7) 884-887; DOI: https://doi.org/10.1124/dmd.105.003822
  3. Baumann, Frank

    1. You have access
      SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA
      Jens Teichert, Reinhard Sohr, Frank Baumann, Lothar Hennig, Karlheinz Merkle, Karel Caca and Rainer Preiss
      Drug Metabolism and Disposition July 2005, 33 (7) 984-992; DOI: https://doi.org/10.1124/dmd.105.003624
  4. Beijnen, Jos H.

    1. You have access
      MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4
      Antonius E. van Herwaarden, Johan W. Smit, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition July 2005, 33 (7) 892-895; DOI: https://doi.org/10.1124/dmd.105.004721
  5. Benlhabib, E.

    1. You have access
      MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234
  6. Bigler, Jeannette

    1. You have access
      GLUCURONIDATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: IDENTIFYING THE ENZYMES RESPONSIBLE IN HUMAN LIVER MICROSOMES
      Gwendolyn E. Kuehl, Johanna W. Lampe, John D. Potter and Jeannette Bigler
      Drug Metabolism and Disposition July 2005, 33 (7) 1027-1035; DOI: https://doi.org/10.1124/dmd.104.002527
  7. Blough, David

    1. You have access
      CONTRIBUTION OF CYP3A5 TO HEPATIC AND RENAL IFOSFAMIDE N-DECHLOROETHYLATION
      Jeannine S. McCune, Linda J. Risler, Brian R. Phillips, Kenneth E. Thummel, David Blough and Danny D. Shen
      Drug Metabolism and Disposition July 2005, 33 (7) 1074-1081; DOI: https://doi.org/10.1124/dmd.104.002279
  8. Boothe-Genthe, Catherine

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  9. Borges, Silvana

    1. You have access
      DEXTROMETHORPHAN TO DEXTRORPHAN URINARY METABOLIC RATIO DOES NOT REFLECT DEXTROMETHORPHAN ORAL CLEARANCE
      Silvana Borges, Lang Li, Mitchell A. Hamman, David R. Jones, Stephen D. Hall and J. Christopher Gorski
      Drug Metabolism and Disposition July 2005, 33 (7) 1052-1055; DOI: https://doi.org/10.1124/dmd.104.003459
  10. Bratton, Stacie

    1. You have access
      LITHOCHOLIC ACID DECREASES EXPRESSION OF UGT2B7 IN CACO-2 CELLS: A POTENTIAL ROLE FOR A NEGATIVE FARNESOID X RECEPTOR RESPONSE ELEMENT
      Yuan Lu, Jean-Marie Heydel, Xin Li, Stacie Bratton, Tim Lindblom and Anna Radominska-Pandya
      Drug Metabolism and Disposition July 2005, 33 (7) 937-946; DOI: https://doi.org/10.1124/dmd.104.003061
  11. Brown, Cheri M.

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  12. Brunner, Janice

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

C

  1. Caca, Karel

    1. You have access
      SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA
      Jens Teichert, Reinhard Sohr, Frank Baumann, Lothar Hennig, Karlheinz Merkle, Karel Caca and Rainer Preiss
      Drug Metabolism and Disposition July 2005, 33 (7) 984-992; DOI: https://doi.org/10.1124/dmd.105.003624
  2. Caldwell, Stuart T.

    1. You have access
      DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS
      Brigitte A. Graf, William Mullen, Stuart T. Caldwell, Richard C. Hartley, Garry G. Duthie, Michael E. J. Lean, Alan Crozier and Christine A. Edwards
      Drug Metabolism and Disposition July 2005, 33 (7) 1036-1043; DOI: https://doi.org/10.1124/dmd.104.002691
  3. Carlini, Edward

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  4. Cascorbi, Ingolf

    1. You have access
      VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
      Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz, Sierk Haenisch, Knud Linnemann, Christoph Fusch, Ingolf Cascorbi and Heyo K. Kroemer
      Drug Metabolism and Disposition July 2005, 33 (7) 896-904; DOI: https://doi.org/10.1124/dmd.104.003335
  5. Catania, Viviana A.

    1. You have access
      PREVENTION OF MRP2 ACTIVITY IMPAIRMENT IN ETHINYLESTRADIOL-INDUCED CHOLESTASIS BY URSODEOXYCHOLATE IN THE RAT
      Fernando A. Crocenzi, Vanesa D'Andrea, Viviana A. Catania, Marcelo G. Luquita, José M. Pellegrino, J. Elena Ochoa, Aldo D. Mottino and Enrique J. Sánchez Pozzi
      Drug Metabolism and Disposition July 2005, 33 (7) 888-891; DOI: https://doi.org/10.1124/dmd.104.003533
  6. Chen, Chuan

    1. You have access
      TISSUE DISTRIBUTION AND ONTOGENY OF MOUSE ORGANIC ANION TRANSPORTING POLYPEPTIDES (OATPS)
      Xingguo Cheng, Jonathan Maher, Chuan Chen and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 1062-1073; DOI: https://doi.org/10.1124/dmd.105.003640
  7. Cheng, Xingguo

    1. You have access
      TISSUE DISTRIBUTION AND ONTOGENY OF MOUSE ORGANIC ANION TRANSPORTING POLYPEPTIDES (OATPS)
      Xingguo Cheng, Jonathan Maher, Chuan Chen and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 1062-1073; DOI: https://doi.org/10.1124/dmd.105.003640
    2. You have access
      TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE
      Jonathan M. Maher, Angela L. Slitt, Nathan J. Cherrington, Xingguo Cheng and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 947-955; DOI: https://doi.org/10.1124/dmd.105.003780
    3. You have access
      INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER
      Jonathan M. Maher, Xingguo Cheng, Angela L. Slitt, Matthew Z. Dieter and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 956-962; DOI: https://doi.org/10.1124/dmd.105.003798
  8. Cherrington, Nathan J.

    1. You have access
      TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE
      Jonathan M. Maher, Angela L. Slitt, Nathan J. Cherrington, Xingguo Cheng and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 947-955; DOI: https://doi.org/10.1124/dmd.105.003780
  9. Chiba, Kan

    1. You have access
      IDENTIFICATION OF HMG-CoA REDUCTASE INHIBITORS AS ACTIVATORS FOR HUMAN, MOUSE AND RAT CONSTITUTIVE ANDROSTANE RECEPTOR
      Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
      Drug Metabolism and Disposition July 2005, 33 (7) 924-929; DOI: https://doi.org/10.1124/dmd.104.002741
  10. Ciecko, Patrice

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  11. Crocenzi, Fernando A.

    1. You have access
      PREVENTION OF MRP2 ACTIVITY IMPAIRMENT IN ETHINYLESTRADIOL-INDUCED CHOLESTASIS BY URSODEOXYCHOLATE IN THE RAT
      Fernando A. Crocenzi, Vanesa D'Andrea, Viviana A. Catania, Marcelo G. Luquita, José M. Pellegrino, J. Elena Ochoa, Aldo D. Mottino and Enrique J. Sánchez Pozzi
      Drug Metabolism and Disposition July 2005, 33 (7) 888-891; DOI: https://doi.org/10.1124/dmd.104.003533
  12. Crozier, Alan

    1. You have access
      DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS
      Brigitte A. Graf, William Mullen, Stuart T. Caldwell, Richard C. Hartley, Garry G. Duthie, Michael E. J. Lean, Alan Crozier and Christine A. Edwards
      Drug Metabolism and Disposition July 2005, 33 (7) 1036-1043; DOI: https://doi.org/10.1124/dmd.104.002691

D

  1. D'Andrea, Vanesa

    1. You have access
      PREVENTION OF MRP2 ACTIVITY IMPAIRMENT IN ETHINYLESTRADIOL-INDUCED CHOLESTASIS BY URSODEOXYCHOLATE IN THE RAT
      Fernando A. Crocenzi, Vanesa D'Andrea, Viviana A. Catania, Marcelo G. Luquita, José M. Pellegrino, J. Elena Ochoa, Aldo D. Mottino and Enrique J. Sánchez Pozzi
      Drug Metabolism and Disposition July 2005, 33 (7) 888-891; DOI: https://doi.org/10.1124/dmd.104.003533
  2. Dieter, Matthew Z.

    1. You have access
      INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER
      Jonathan M. Maher, Xingguo Cheng, Angela L. Slitt, Matthew Z. Dieter and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 956-962; DOI: https://doi.org/10.1124/dmd.105.003798
  3. Dong, Junxing

    1. You have access
      METABOLIC PROFILE OF 1,5-DICAFFEOYLQUINIC ACID IN RATS, AN IN VIVO AND IN VITRO STUDY
      Bo Yang, Zhiyun Meng, Junxing Dong, Liangping Yan, Libo Zou, Zhongming Tang and Guifang Dou
      Drug Metabolism and Disposition July 2005, 33 (7) 930-936; DOI: https://doi.org/10.1124/dmd.104.002154
  4. Dou, Guifang

    1. You have access
      METABOLIC PROFILE OF 1,5-DICAFFEOYLQUINIC ACID IN RATS, AN IN VIVO AND IN VITRO STUDY
      Bo Yang, Zhiyun Meng, Junxing Dong, Liangping Yan, Libo Zou, Zhongming Tang and Guifang Dou
      Drug Metabolism and Disposition July 2005, 33 (7) 930-936; DOI: https://doi.org/10.1124/dmd.104.002154
  5. Duthie, Garry G.

    1. You have access
      DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS
      Brigitte A. Graf, William Mullen, Stuart T. Caldwell, Richard C. Hartley, Garry G. Duthie, Michael E. J. Lean, Alan Crozier and Christine A. Edwards
      Drug Metabolism and Disposition July 2005, 33 (7) 1036-1043; DOI: https://doi.org/10.1124/dmd.104.002691

E

  1. Edwards, Christine A.

    1. You have access
      DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS
      Brigitte A. Graf, William Mullen, Stuart T. Caldwell, Richard C. Hartley, Garry G. Duthie, Michael E. J. Lean, Alan Crozier and Christine A. Edwards
      Drug Metabolism and Disposition July 2005, 33 (7) 1036-1043; DOI: https://doi.org/10.1124/dmd.104.002691
  2. Evans, Ronald M.

    1. You have access
      ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954

F

  1. Finel, Moshe

    1. You have access
      KINETIC CHARACTERIZATION OF THE 1A SUBFAMILY OF RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Leena Luukkanen, Jyrki Taskinen, Mika Kurkela, Risto Kostiainen, Jouni Hirvonen and Moshe Finel
      Drug Metabolism and Disposition July 2005, 33 (7) 1017-1026; DOI: https://doi.org/10.1124/dmd.105.004093
  2. Fuller, S.

    1. You have access
      MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234
  3. Fusch, Christoph

    1. You have access
      VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
      Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz, Sierk Haenisch, Knud Linnemann, Christoph Fusch, Ingolf Cascorbi and Heyo K. Kroemer
      Drug Metabolism and Disposition July 2005, 33 (7) 896-904; DOI: https://doi.org/10.1124/dmd.104.003335
  4. Fuse, Eiichi

    1. You have access
      P-GLYCOPROTEIN PLAYS A MAJOR ROLE IN THE EFFLUX OF FEXOFENADINE IN THE SMALL INTESTINE AND BLOOD-BRAIN BARRIER, BUT ONLY A LIMITED ROLE IN ITS BILIARY EXCRETION
      Harunobu Tahara, Hiroyuki Kusuhara, Eiichi Fuse and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2005, 33 (7) 963-968; DOI: https://doi.org/10.1124/dmd.105.004192

G

  1. Gibson, Christopher R.

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  2. Gorski, J. Christopher

    1. You have access
      DEXTROMETHORPHAN TO DEXTRORPHAN URINARY METABOLIC RATIO DOES NOT REFLECT DEXTROMETHORPHAN ORAL CLEARANCE
      Silvana Borges, Lang Li, Mitchell A. Hamman, David R. Jones, Stephen D. Hall and J. Christopher Gorski
      Drug Metabolism and Disposition July 2005, 33 (7) 1052-1055; DOI: https://doi.org/10.1124/dmd.104.003459
  3. Gotoh, Yukiko

    1. You have access
      REGULATION OF THE CELL SURFACE EXPRESSION OF HUMAN BCRP/ABCG2 BY THE PHOSPHORYLATION STATE OF AKT IN POLARIZED CELLS
      Tappei Takada, Hiroshi Suzuki, Yukiko Gotoh and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2005, 33 (7) 905-909; DOI: https://doi.org/10.1124/dmd.104.003228
  4. Graf, Brigitte A.

    1. You have access
      DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS
      Brigitte A. Graf, William Mullen, Stuart T. Caldwell, Richard C. Hartley, Garry G. Duthie, Michael E. J. Lean, Alan Crozier and Christine A. Edwards
      Drug Metabolism and Disposition July 2005, 33 (7) 1036-1043; DOI: https://doi.org/10.1124/dmd.104.002691
  5. Gräter, Frauke

    1. You have access
      POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION
      Weihua Li, Hong Liu, Emily E. Scott, Frauke Gräter, James R. Halpert, Xiaoming Luo, Jianhua Shen and Hualiang Jiang
      Drug Metabolism and Disposition July 2005, 33 (7) 910-919; DOI: https://doi.org/10.1124/dmd.105.004200
  6. Gratz, Matthias

    1. You have access
      VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
      Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz, Sierk Haenisch, Knud Linnemann, Christoph Fusch, Ingolf Cascorbi and Heyo K. Kroemer
      Drug Metabolism and Disposition July 2005, 33 (7) 896-904; DOI: https://doi.org/10.1124/dmd.104.003335

H

  1. Haenisch, Sierk

    1. You have access
      VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
      Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz, Sierk Haenisch, Knud Linnemann, Christoph Fusch, Ingolf Cascorbi and Heyo K. Kroemer
      Drug Metabolism and Disposition July 2005, 33 (7) 896-904; DOI: https://doi.org/10.1124/dmd.104.003335
  2. Hall, Stephen D.

    1. You have access
      DEXTROMETHORPHAN TO DEXTRORPHAN URINARY METABOLIC RATIO DOES NOT REFLECT DEXTROMETHORPHAN ORAL CLEARANCE
      Silvana Borges, Lang Li, Mitchell A. Hamman, David R. Jones, Stephen D. Hall and J. Christopher Gorski
      Drug Metabolism and Disposition July 2005, 33 (7) 1052-1055; DOI: https://doi.org/10.1124/dmd.104.003459
  3. Halpert, James R.

    1. You have access
      POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION
      Weihua Li, Hong Liu, Emily E. Scott, Frauke Gräter, James R. Halpert, Xiaoming Luo, Jianhua Shen and Hualiang Jiang
      Drug Metabolism and Disposition July 2005, 33 (7) 910-919; DOI: https://doi.org/10.1124/dmd.105.004200
  4. Hamman, Mitchell A.

    1. You have access
      DEXTROMETHORPHAN TO DEXTRORPHAN URINARY METABOLIC RATIO DOES NOT REFLECT DEXTROMETHORPHAN ORAL CLEARANCE
      Silvana Borges, Lang Li, Mitchell A. Hamman, David R. Jones, Stephen D. Hall and J. Christopher Gorski
      Drug Metabolism and Disposition July 2005, 33 (7) 1052-1055; DOI: https://doi.org/10.1124/dmd.104.003459
  5. Hartley, Richard C.

    1. You have access
      DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS
      Brigitte A. Graf, William Mullen, Stuart T. Caldwell, Richard C. Hartley, Garry G. Duthie, Michael E. J. Lean, Alan Crozier and Christine A. Edwards
      Drug Metabolism and Disposition July 2005, 33 (7) 1036-1043; DOI: https://doi.org/10.1124/dmd.104.002691
  6. Hendrickx, Jan

    1. You have access
      EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046
  7. Hennig, Lothar

    1. You have access
      SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA
      Jens Teichert, Reinhard Sohr, Frank Baumann, Lothar Hennig, Karlheinz Merkle, Karel Caca and Rainer Preiss
      Drug Metabolism and Disposition July 2005, 33 (7) 984-992; DOI: https://doi.org/10.1124/dmd.105.003624
  8. Heydel, Jean-Marie

    1. You have access
      LITHOCHOLIC ACID DECREASES EXPRESSION OF UGT2B7 IN CACO-2 CELLS: A POTENTIAL ROLE FOR A NEGATIVE FARNESOID X RECEPTOR RESPONSE ELEMENT
      Yuan Lu, Jean-Marie Heydel, Xin Li, Stacie Bratton, Tim Lindblom and Anna Radominska-Pandya
      Drug Metabolism and Disposition July 2005, 33 (7) 937-946; DOI: https://doi.org/10.1124/dmd.104.003061
  9. Hirvonen, Jouni

    1. You have access
      KINETIC CHARACTERIZATION OF THE 1A SUBFAMILY OF RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Leena Luukkanen, Jyrki Taskinen, Mika Kurkela, Risto Kostiainen, Jouni Hirvonen and Moshe Finel
      Drug Metabolism and Disposition July 2005, 33 (7) 1017-1026; DOI: https://doi.org/10.1124/dmd.105.004093
  10. Hosokawa, Masakiyo

    1. You have access
      IDENTIFICATION OF HMG-CoA REDUCTASE INHIBITORS AS ACTIVATORS FOR HUMAN, MOUSE AND RAT CONSTITUTIVE ANDROSTANE RECEPTOR
      Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
      Drug Metabolism and Disposition July 2005, 33 (7) 924-929; DOI: https://doi.org/10.1124/dmd.104.002741

I

  1. Iwazaki, Norihiko

    1. You have access
      IDENTIFICATION OF HMG-CoA REDUCTASE INHIBITORS AS ACTIVATORS FOR HUMAN, MOUSE AND RAT CONSTITUTIVE ANDROSTANE RECEPTOR
      Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
      Drug Metabolism and Disposition July 2005, 33 (7) 924-929; DOI: https://doi.org/10.1124/dmd.104.002741

J

  1. Jacobs, Judith M.

    1. You have access
      ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954
  2. Jedlitschky, Gabriele

    1. You have access
      VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
      Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz, Sierk Haenisch, Knud Linnemann, Christoph Fusch, Ingolf Cascorbi and Heyo K. Kroemer
      Drug Metabolism and Disposition July 2005, 33 (7) 896-904; DOI: https://doi.org/10.1124/dmd.104.003335
  3. Jiang, Hualiang

    1. You have access
      POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION
      Weihua Li, Hong Liu, Emily E. Scott, Frauke Gräter, James R. Halpert, Xiaoming Luo, Jianhua Shen and Hualiang Jiang
      Drug Metabolism and Disposition July 2005, 33 (7) 910-919; DOI: https://doi.org/10.1124/dmd.105.004200
  4. Jones, David R.

    1. You have access
      DEXTROMETHORPHAN TO DEXTRORPHAN URINARY METABOLIC RATIO DOES NOT REFLECT DEXTROMETHORPHAN ORAL CLEARANCE
      Silvana Borges, Lang Li, Mitchell A. Hamman, David R. Jones, Stephen D. Hall and J. Christopher Gorski
      Drug Metabolism and Disposition July 2005, 33 (7) 1052-1055; DOI: https://doi.org/10.1124/dmd.104.003459

K

  1. Kamel, Amin

    1. You have access
      CHARACTERIZATION OF A NOVEL METABOLITE INTERMEDIATE OF ZIPRASIDONE IN HEPATIC CYTOSOLIC FRACTIONS OF RAT, DOG, AND HUMAN BY ESI-MS/MS, HYDROGEN/DEUTERIUM EXCHANGE, AND CHEMICAL DERIVATIZATION
      Zhuang Miao, Amin Kamel and Chandra Prakash
      Drug Metabolism and Disposition July 2005, 33 (7) 879-883; DOI: https://doi.org/10.1124/dmd.105.004036
  2. Keyler, D. E.

    1. You have access
      MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234
  3. Klaassen, Curtis D.

    1. You have access
      TISSUE DISTRIBUTION AND ONTOGENY OF MOUSE ORGANIC ANION TRANSPORTING POLYPEPTIDES (OATPS)
      Xingguo Cheng, Jonathan Maher, Chuan Chen and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 1062-1073; DOI: https://doi.org/10.1124/dmd.105.003640
    2. You have access
      TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE
      Jonathan M. Maher, Angela L. Slitt, Nathan J. Cherrington, Xingguo Cheng and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 947-955; DOI: https://doi.org/10.1124/dmd.105.003780
    3. You have access
      INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER
      Jonathan M. Maher, Xingguo Cheng, Angela L. Slitt, Matthew Z. Dieter and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 956-962; DOI: https://doi.org/10.1124/dmd.105.003798
  4. Kobayashi, Kaoru

    1. You have access
      IDENTIFICATION OF HMG-CoA REDUCTASE INHIBITORS AS ACTIVATORS FOR HUMAN, MOUSE AND RAT CONSTITUTIVE ANDROSTANE RECEPTOR
      Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
      Drug Metabolism and Disposition July 2005, 33 (7) 924-929; DOI: https://doi.org/10.1124/dmd.104.002741
  5. Kostiainen, Risto

    1. You have access
      KINETIC CHARACTERIZATION OF THE 1A SUBFAMILY OF RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Leena Luukkanen, Jyrki Taskinen, Mika Kurkela, Risto Kostiainen, Jouni Hirvonen and Moshe Finel
      Drug Metabolism and Disposition July 2005, 33 (7) 1017-1026; DOI: https://doi.org/10.1124/dmd.105.004093
  6. Kostrubsky, Vsevolod E.

    1. You have access
      ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954
  7. Kroemer, Heyo K.

    1. You have access
      VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
      Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz, Sierk Haenisch, Knud Linnemann, Christoph Fusch, Ingolf Cascorbi and Heyo K. Kroemer
      Drug Metabolism and Disposition July 2005, 33 (7) 896-904; DOI: https://doi.org/10.1124/dmd.104.003335
  8. Krolikowski, Paul

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  9. Kuehl, Gwendolyn E.

    1. You have access
      GLUCURONIDATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: IDENTIFYING THE ENZYMES RESPONSIBLE IN HUMAN LIVER MICROSOMES
      Gwendolyn E. Kuehl, Johanna W. Lampe, John D. Potter and Jeannette Bigler
      Drug Metabolism and Disposition July 2005, 33 (7) 1027-1035; DOI: https://doi.org/10.1124/dmd.104.002527
  10. Kurkela, Mika

    1. You have access
      KINETIC CHARACTERIZATION OF THE 1A SUBFAMILY OF RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Leena Luukkanen, Jyrki Taskinen, Mika Kurkela, Risto Kostiainen, Jouni Hirvonen and Moshe Finel
      Drug Metabolism and Disposition July 2005, 33 (7) 1017-1026; DOI: https://doi.org/10.1124/dmd.105.004093
  11. Kusuhara, Hiroyuki

    1. You have access
      P-GLYCOPROTEIN PLAYS A MAJOR ROLE IN THE EFFLUX OF FEXOFENADINE IN THE SMALL INTESTINE AND BLOOD-BRAIN BARRIER, BUT ONLY A LIMITED ROLE IN ITS BILIARY EXCRETION
      Harunobu Tahara, Hiroyuki Kusuhara, Eiichi Fuse and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2005, 33 (7) 963-968; DOI: https://doi.org/10.1124/dmd.105.004192

L

  1. Lajoie, Julie

    1. You have access
      CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS
      Jean-Nicholas Roy, Julie Lajoie, Lynn S. Zijenah, Azemi Barama, Charles Poirier, Brian J. Ward and Michel Roger
      Drug Metabolism and Disposition July 2005, 33 (7) 884-887; DOI: https://doi.org/10.1124/dmd.105.003822
  2. Lampe, Johanna W.

    1. You have access
      GLUCURONIDATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: IDENTIFYING THE ENZYMES RESPONSIBLE IN HUMAN LIVER MICROSOMES
      Gwendolyn E. Kuehl, Johanna W. Lampe, John D. Potter and Jeannette Bigler
      Drug Metabolism and Disposition July 2005, 33 (7) 1027-1035; DOI: https://doi.org/10.1124/dmd.104.002527
  3. Le, C. T.

    1. You have access
      MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234
  4. Lean, Michael E. J.

    1. You have access
      DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS
      Brigitte A. Graf, William Mullen, Stuart T. Caldwell, Richard C. Hartley, Garry G. Duthie, Michael E. J. Lean, Alan Crozier and Christine A. Edwards
      Drug Metabolism and Disposition July 2005, 33 (7) 1036-1043; DOI: https://doi.org/10.1124/dmd.104.002691
  5. LeSage, M. G.

    1. You have access
      MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234
  6. Li, Lang

    1. You have access
      DEXTROMETHORPHAN TO DEXTRORPHAN URINARY METABOLIC RATIO DOES NOT REFLECT DEXTROMETHORPHAN ORAL CLEARANCE
      Silvana Borges, Lang Li, Mitchell A. Hamman, David R. Jones, Stephen D. Hall and J. Christopher Gorski
      Drug Metabolism and Disposition July 2005, 33 (7) 1052-1055; DOI: https://doi.org/10.1124/dmd.104.003459
  7. Li, Weihua

    1. You have access
      POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION
      Weihua Li, Hong Liu, Emily E. Scott, Frauke Gräter, James R. Halpert, Xiaoming Luo, Jianhua Shen and Hualiang Jiang
      Drug Metabolism and Disposition July 2005, 33 (7) 910-919; DOI: https://doi.org/10.1124/dmd.105.004200
  8. Li, Xin

    1. You have access
      LITHOCHOLIC ACID DECREASES EXPRESSION OF UGT2B7 IN CACO-2 CELLS: A POTENTIAL ROLE FOR A NEGATIVE FARNESOID X RECEPTOR RESPONSE ELEMENT
      Yuan Lu, Jean-Marie Heydel, Xin Li, Stacie Bratton, Tim Lindblom and Anna Radominska-Pandya
      Drug Metabolism and Disposition July 2005, 33 (7) 937-946; DOI: https://doi.org/10.1124/dmd.104.003061
  9. Lin, Charles

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  10. Lindblom, Tim

    1. You have access
      LITHOCHOLIC ACID DECREASES EXPRESSION OF UGT2B7 IN CACO-2 CELLS: A POTENTIAL ROLE FOR A NEGATIVE FARNESOID X RECEPTOR RESPONSE ELEMENT
      Yuan Lu, Jean-Marie Heydel, Xin Li, Stacie Bratton, Tim Lindblom and Anna Radominska-Pandya
      Drug Metabolism and Disposition July 2005, 33 (7) 937-946; DOI: https://doi.org/10.1124/dmd.104.003061
  11. Linnemann, Knud

    1. You have access
      VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
      Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz, Sierk Haenisch, Knud Linnemann, Christoph Fusch, Ingolf Cascorbi and Heyo K. Kroemer
      Drug Metabolism and Disposition July 2005, 33 (7) 896-904; DOI: https://doi.org/10.1124/dmd.104.003335
  12. Liu, Hong

    1. You have access
      POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION
      Weihua Li, Hong Liu, Emily E. Scott, Frauke Gräter, James R. Halpert, Xiaoming Luo, Jianhua Shen and Hualiang Jiang
      Drug Metabolism and Disposition July 2005, 33 (7) 910-919; DOI: https://doi.org/10.1124/dmd.105.004200
  13. Locuson, Charles W.

    1. You have access
      THREE-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP ANALYSIS OF CYTOCHROMES P450: EFFECT OF INCORPORATING HIGHER-AFFINITY LIGANDS AND POTENTIAL NEW APPLICATIONS
      Charles W. Locuson and Jan L. Wahlstrom
      Drug Metabolism and Disposition July 2005, 33 (7) 873-878; DOI: https://doi.org/10.1124/dmd.105.004325
  14. Lu, Yuan

    1. You have access
      LITHOCHOLIC ACID DECREASES EXPRESSION OF UGT2B7 IN CACO-2 CELLS: A POTENTIAL ROLE FOR A NEGATIVE FARNESOID X RECEPTOR RESPONSE ELEMENT
      Yuan Lu, Jean-Marie Heydel, Xin Li, Stacie Bratton, Tim Lindblom and Anna Radominska-Pandya
      Drug Metabolism and Disposition July 2005, 33 (7) 937-946; DOI: https://doi.org/10.1124/dmd.104.003061
  15. Luo, Xiaoming

    1. You have access
      POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION
      Weihua Li, Hong Liu, Emily E. Scott, Frauke Gräter, James R. Halpert, Xiaoming Luo, Jianhua Shen and Hualiang Jiang
      Drug Metabolism and Disposition July 2005, 33 (7) 910-919; DOI: https://doi.org/10.1124/dmd.105.004200
  16. Luquita, Marcelo G.

    1. You have access
      PREVENTION OF MRP2 ACTIVITY IMPAIRMENT IN ETHINYLESTRADIOL-INDUCED CHOLESTASIS BY URSODEOXYCHOLATE IN THE RAT
      Fernando A. Crocenzi, Vanesa D'Andrea, Viviana A. Catania, Marcelo G. Luquita, José M. Pellegrino, J. Elena Ochoa, Aldo D. Mottino and Enrique J. Sánchez Pozzi
      Drug Metabolism and Disposition July 2005, 33 (7) 888-891; DOI: https://doi.org/10.1124/dmd.104.003533
  17. Luu, Minh

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  18. Luukkanen, Leena

    1. You have access
      KINETIC CHARACTERIZATION OF THE 1A SUBFAMILY OF RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Leena Luukkanen, Jyrki Taskinen, Mika Kurkela, Risto Kostiainen, Jouni Hirvonen and Moshe Finel
      Drug Metabolism and Disposition July 2005, 33 (7) 1017-1026; DOI: https://doi.org/10.1124/dmd.105.004093

M

  1. Maher, Jonathan

    1. You have access
      TISSUE DISTRIBUTION AND ONTOGENY OF MOUSE ORGANIC ANION TRANSPORTING POLYPEPTIDES (OATPS)
      Xingguo Cheng, Jonathan Maher, Chuan Chen and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 1062-1073; DOI: https://doi.org/10.1124/dmd.105.003640
  2. Maher, Jonathan M.

    1. You have access
      TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE
      Jonathan M. Maher, Angela L. Slitt, Nathan J. Cherrington, Xingguo Cheng and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 947-955; DOI: https://doi.org/10.1124/dmd.105.003780
    2. You have access
      INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER
      Jonathan M. Maher, Xingguo Cheng, Angela L. Slitt, Matthew Z. Dieter and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 956-962; DOI: https://doi.org/10.1124/dmd.105.003798
  3. Mannens, Geert

    1. You have access
      EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046
  4. McCune, Jeannine S.

    1. You have access
      CONTRIBUTION OF CYP3A5 TO HEPATIC AND RENAL IFOSFAMIDE N-DECHLOROETHYLATION
      Jeannine S. McCune, Linda J. Risler, Brian R. Phillips, Kenneth E. Thummel, David Blough and Danny D. Shen
      Drug Metabolism and Disposition July 2005, 33 (7) 1074-1081; DOI: https://doi.org/10.1124/dmd.104.002279
  5. Meng, Zhiyun

    1. You have access
      METABOLIC PROFILE OF 1,5-DICAFFEOYLQUINIC ACID IN RATS, AN IN VIVO AND IN VITRO STUDY
      Bo Yang, Zhiyun Meng, Junxing Dong, Liangping Yan, Libo Zou, Zhongming Tang and Guifang Dou
      Drug Metabolism and Disposition July 2005, 33 (7) 930-936; DOI: https://doi.org/10.1124/dmd.104.002154
  6. Merkle, Karlheinz

    1. You have access
      SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA
      Jens Teichert, Reinhard Sohr, Frank Baumann, Lothar Hennig, Karlheinz Merkle, Karel Caca and Rainer Preiss
      Drug Metabolism and Disposition July 2005, 33 (7) 984-992; DOI: https://doi.org/10.1124/dmd.105.003624
  7. Meuldermans, Willem

    1. You have access
      EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046
  8. Meyer zu Schwabedissen, Henriette E.

    1. You have access
      VARIABLE EXPRESSION OF MRP2 (ABCC2) IN HUMAN PLACENTA: INFLUENCE OF GESTATIONAL AGE AND CELLULAR DIFFERENTIATION
      Henriette E. Meyer zu Schwabedissen, Gabriele Jedlitschky, Matthias Gratz, Sierk Haenisch, Knud Linnemann, Christoph Fusch, Ingolf Cascorbi and Heyo K. Kroemer
      Drug Metabolism and Disposition July 2005, 33 (7) 896-904; DOI: https://doi.org/10.1124/dmd.104.003335
  9. Miao, Zhuang

    1. You have access
      CHARACTERIZATION OF A NOVEL METABOLITE INTERMEDIATE OF ZIPRASIDONE IN HEPATIC CYTOSOLIC FRACTIONS OF RAT, DOG, AND HUMAN BY ESI-MS/MS, HYDROGEN/DEUTERIUM EXCHANGE, AND CHEMICAL DERIVATIZATION
      Zhuang Miao, Amin Kamel and Chandra Prakash
      Drug Metabolism and Disposition July 2005, 33 (7) 879-883; DOI: https://doi.org/10.1124/dmd.105.004036
  10. Michael, Aimee

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  11. Michel, Kimberly

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  12. Mohutsky, Michael A.

    1. You have access
      THE USE OF A SUBSTRATE CASSETTE STRATEGY TO IMPROVE THE CAPACITY AND THROUGHPUT OF CYTOCHROME P450 INDUCTION STUDIES IN HUMAN HEPATOCYTES
      Michael A. Mohutsky, David M. Petullo and Steven A. Wrighton
      Drug Metabolism and Disposition July 2005, 33 (7) 920-923; DOI: https://doi.org/10.1124/dmd.105.004291
  13. Mottino, Aldo D.

    1. You have access
      PREVENTION OF MRP2 ACTIVITY IMPAIRMENT IN ETHINYLESTRADIOL-INDUCED CHOLESTASIS BY URSODEOXYCHOLATE IN THE RAT
      Fernando A. Crocenzi, Vanesa D'Andrea, Viviana A. Catania, Marcelo G. Luquita, José M. Pellegrino, J. Elena Ochoa, Aldo D. Mottino and Enrique J. Sánchez Pozzi
      Drug Metabolism and Disposition July 2005, 33 (7) 888-891; DOI: https://doi.org/10.1124/dmd.104.003533
  14. Mullen, William

    1. You have access
      DISPOSITION AND METABOLISM OF [2-14C]QUERCETIN-4′-GLUCOSIDE IN RATS
      Brigitte A. Graf, William Mullen, Stuart T. Caldwell, Richard C. Hartley, Garry G. Duthie, Michael E. J. Lean, Alan Crozier and Christine A. Edwards
      Drug Metabolism and Disposition July 2005, 33 (7) 1036-1043; DOI: https://doi.org/10.1124/dmd.104.002691

N

  1. Nakajo, Ikumi

    1. You have access
      IDENTIFICATION OF HMG-CoA REDUCTASE INHIBITORS AS ACTIVATORS FOR HUMAN, MOUSE AND RAT CONSTITUTIVE ANDROSTANE RECEPTOR
      Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
      Drug Metabolism and Disposition July 2005, 33 (7) 924-929; DOI: https://doi.org/10.1124/dmd.104.002741
  2. Negishi, Masahiko

    1. You have access
      IDENTIFICATION OF HMG-CoA REDUCTASE INHIBITORS AS ACTIVATORS FOR HUMAN, MOUSE AND RAT CONSTITUTIVE ANDROSTANE RECEPTOR
      Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
      Drug Metabolism and Disposition July 2005, 33 (7) 924-929; DOI: https://doi.org/10.1124/dmd.104.002741
  3. Nichols, Ralph C.

    1. You have access
      ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954
  4. Noreault, Trisha L.

    1. You have access
      ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954
  5. Noukens, Jan

    1. You have access
      EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046

O

  1. Ochoa, J. Elena

    1. You have access
      PREVENTION OF MRP2 ACTIVITY IMPAIRMENT IN ETHINYLESTRADIOL-INDUCED CHOLESTASIS BY URSODEOXYCHOLATE IN THE RAT
      Fernando A. Crocenzi, Vanesa D'Andrea, Viviana A. Catania, Marcelo G. Luquita, José M. Pellegrino, J. Elena Ochoa, Aldo D. Mottino and Enrique J. Sánchez Pozzi
      Drug Metabolism and Disposition July 2005, 33 (7) 888-891; DOI: https://doi.org/10.1124/dmd.104.003533

P

  1. Parikh, Mona

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  2. Pellegrino, José M.

    1. You have access
      PREVENTION OF MRP2 ACTIVITY IMPAIRMENT IN ETHINYLESTRADIOL-INDUCED CHOLESTASIS BY URSODEOXYCHOLATE IN THE RAT
      Fernando A. Crocenzi, Vanesa D'Andrea, Viviana A. Catania, Marcelo G. Luquita, José M. Pellegrino, J. Elena Ochoa, Aldo D. Mottino and Enrique J. Sánchez Pozzi
      Drug Metabolism and Disposition July 2005, 33 (7) 888-891; DOI: https://doi.org/10.1124/dmd.104.003533
  3. Pentel, P. R.

    1. You have access
      MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234
  4. Petullo, David M.

    1. You have access
      THE USE OF A SUBSTRATE CASSETTE STRATEGY TO IMPROVE THE CAPACITY AND THROUGHPUT OF CYTOCHROME P450 INDUCTION STUDIES IN HUMAN HEPATOCYTES
      Michael A. Mohutsky, David M. Petullo and Steven A. Wrighton
      Drug Metabolism and Disposition July 2005, 33 (7) 920-923; DOI: https://doi.org/10.1124/dmd.105.004291
  5. Phillips, Brian R.

    1. You have access
      CONTRIBUTION OF CYP3A5 TO HEPATIC AND RENAL IFOSFAMIDE N-DECHLOROETHYLATION
      Jeannine S. McCune, Linda J. Risler, Brian R. Phillips, Kenneth E. Thummel, David Blough and Danny D. Shen
      Drug Metabolism and Disposition July 2005, 33 (7) 1074-1081; DOI: https://doi.org/10.1124/dmd.104.002279
  6. Poirier, Charles

    1. You have access
      CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS
      Jean-Nicholas Roy, Julie Lajoie, Lynn S. Zijenah, Azemi Barama, Charles Poirier, Brian J. Ward and Michel Roger
      Drug Metabolism and Disposition July 2005, 33 (7) 884-887; DOI: https://doi.org/10.1124/dmd.105.003822
  7. Potter, John D.

    1. You have access
      GLUCURONIDATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: IDENTIFYING THE ENZYMES RESPONSIBLE IN HUMAN LIVER MICROSOMES
      Gwendolyn E. Kuehl, Johanna W. Lampe, John D. Potter and Jeannette Bigler
      Drug Metabolism and Disposition July 2005, 33 (7) 1027-1035; DOI: https://doi.org/10.1124/dmd.104.002527
  8. Prakash, Chandra

    1. You have access
      CHARACTERIZATION OF A NOVEL METABOLITE INTERMEDIATE OF ZIPRASIDONE IN HEPATIC CYTOSOLIC FRACTIONS OF RAT, DOG, AND HUMAN BY ESI-MS/MS, HYDROGEN/DEUTERIUM EXCHANGE, AND CHEMICAL DERIVATIZATION
      Zhuang Miao, Amin Kamel and Chandra Prakash
      Drug Metabolism and Disposition July 2005, 33 (7) 879-883; DOI: https://doi.org/10.1124/dmd.105.004036
  9. Preiss, Rainer

    1. You have access
      SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA
      Jens Teichert, Reinhard Sohr, Frank Baumann, Lothar Hennig, Karlheinz Merkle, Karel Caca and Rainer Preiss
      Drug Metabolism and Disposition July 2005, 33 (7) 984-992; DOI: https://doi.org/10.1124/dmd.105.003624

R

  1. Raab, Conrad

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  2. Radominska-Pandya, Anna

    1. You have access
      LITHOCHOLIC ACID DECREASES EXPRESSION OF UGT2B7 IN CACO-2 CELLS: A POTENTIAL ROLE FOR A NEGATIVE FARNESOID X RECEPTOR RESPONSE ELEMENT
      Yuan Lu, Jean-Marie Heydel, Xin Li, Stacie Bratton, Tim Lindblom and Anna Radominska-Pandya
      Drug Metabolism and Disposition July 2005, 33 (7) 937-946; DOI: https://doi.org/10.1124/dmd.104.003061
  3. Richards, Karen

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  4. Risler, Linda J.

    1. You have access
      CONTRIBUTION OF CYP3A5 TO HEPATIC AND RENAL IFOSFAMIDE N-DECHLOROETHYLATION
      Jeannine S. McCune, Linda J. Risler, Brian R. Phillips, Kenneth E. Thummel, David Blough and Danny D. Shen
      Drug Metabolism and Disposition July 2005, 33 (7) 1074-1081; DOI: https://doi.org/10.1124/dmd.104.002279
  5. Ritter, Joseph K.

    1. You have access
      DIFFERENTIAL RATES OF GLUCURONIDATION FOR 7-ETHYL-10-HYDROXY-CAMPTOTHECIN (SN-38) LACTONE AND CARBOXYLATE IN HUMAN AND RAT MICROSOMES AND RECOMBINANT UDP-GLUCURONOSYLTRANSFERASE ISOFORMS
      Melanie N. Tallman, Joseph K. Ritter and Philip C. Smith
      Drug Metabolism and Disposition July 2005, 33 (7) 977-983; DOI: https://doi.org/10.1124/dmd.104.003491
  6. Rodrigues, A. David

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  7. Roger, Michel

    1. You have access
      CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS
      Jean-Nicholas Roy, Julie Lajoie, Lynn S. Zijenah, Azemi Barama, Charles Poirier, Brian J. Ward and Michel Roger
      Drug Metabolism and Disposition July 2005, 33 (7) 884-887; DOI: https://doi.org/10.1124/dmd.105.003822
  8. Roiko, S. A.

    1. You have access
      MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234
  9. Roy, Jean-Nicholas

    1. You have access
      CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS
      Jean-Nicholas Roy, Julie Lajoie, Lynn S. Zijenah, Azemi Barama, Charles Poirier, Brian J. Ward and Michel Roger
      Drug Metabolism and Disposition July 2005, 33 (7) 884-887; DOI: https://doi.org/10.1124/dmd.105.003822
  10. Roymans, Dirk

    1. You have access
      EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046
  11. Rushmore, Thomas H.

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913

S

  1. Sánchez Pozzi, Enrique J.

    1. You have access
      PREVENTION OF MRP2 ACTIVITY IMPAIRMENT IN ETHINYLESTRADIOL-INDUCED CHOLESTASIS BY URSODEOXYCHOLATE IN THE RAT
      Fernando A. Crocenzi, Vanesa D'Andrea, Viviana A. Catania, Marcelo G. Luquita, José M. Pellegrino, J. Elena Ochoa, Aldo D. Mottino and Enrique J. Sánchez Pozzi
      Drug Metabolism and Disposition July 2005, 33 (7) 888-891; DOI: https://doi.org/10.1124/dmd.104.003533
  2. Schellens, Jan H. M.

    1. You have access
      MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4
      Antonius E. van Herwaarden, Johan W. Smit, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition July 2005, 33 (7) 892-895; DOI: https://doi.org/10.1124/dmd.105.004721
  3. Schinkel, Alfred H.

    1. You have access
      MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4
      Antonius E. van Herwaarden, Johan W. Smit, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition July 2005, 33 (7) 892-895; DOI: https://doi.org/10.1124/dmd.105.004721
  4. Scott, Emily E.

    1. You have access
      POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION
      Weihua Li, Hong Liu, Emily E. Scott, Frauke Gräter, James R. Halpert, Xiaoming Luo, Jianhua Shen and Hualiang Jiang
      Drug Metabolism and Disposition July 2005, 33 (7) 910-919; DOI: https://doi.org/10.1124/dmd.105.004200
  5. Sensenhauser, Carlo

    1. You have access
      EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046
  6. Shen, Danny D.

    1. You have access
      CONTRIBUTION OF CYP3A5 TO HEPATIC AND RENAL IFOSFAMIDE N-DECHLOROETHYLATION
      Jeannine S. McCune, Linda J. Risler, Brian R. Phillips, Kenneth E. Thummel, David Blough and Danny D. Shen
      Drug Metabolism and Disposition July 2005, 33 (7) 1074-1081; DOI: https://doi.org/10.1124/dmd.104.002279
  7. Shen, Jianhua

    1. You have access
      POSSIBLE PATHWAY(S) OF TESTOSTERONE EGRESS FROM THE ACTIVE SITE OF CYTOCHROME P450 2B1: A STEERED MOLECULAR DYNAMICS SIMULATION
      Weihua Li, Hong Liu, Emily E. Scott, Frauke Gräter, James R. Halpert, Xiaoming Luo, Jianhua Shen and Hualiang Jiang
      Drug Metabolism and Disposition July 2005, 33 (7) 910-919; DOI: https://doi.org/10.1124/dmd.105.004200
  8. Silva, José

    1. You have access
      EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046
  9. Sinclair, Jacqueline F.

    1. You have access
      ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954
  10. Sinclair, Peter R.

    1. You have access
      ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954
  11. Singh, Rominder

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  12. Slitt, Angela L.

    1. You have access
      TISSUE DISTRIBUTION AND HEPATIC AND RENAL ONTOGENY OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) FAMILY IN MICE
      Jonathan M. Maher, Angela L. Slitt, Nathan J. Cherrington, Xingguo Cheng and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 947-955; DOI: https://doi.org/10.1124/dmd.105.003780
    2. You have access
      INDUCTION OF THE MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN FAMILY OF TRANSPORTERS BY CHEMICAL ACTIVATORS OF RECEPTOR-MEDIATED PATHWAYS IN MOUSE LIVER
      Jonathan M. Maher, Xingguo Cheng, Angela L. Slitt, Matthew Z. Dieter and Curtis D. Klaassen
      Drug Metabolism and Disposition July 2005, 33 (7) 956-962; DOI: https://doi.org/10.1124/dmd.105.003798
  13. Smit, Johan W.

    1. You have access
      MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4
      Antonius E. van Herwaarden, Johan W. Smit, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition July 2005, 33 (7) 892-895; DOI: https://doi.org/10.1124/dmd.105.004721
  14. Smith, Philip C.

    1. You have access
      DIFFERENTIAL RATES OF GLUCURONIDATION FOR 7-ETHYL-10-HYDROXY-CAMPTOTHECIN (SN-38) LACTONE AND CARBOXYLATE IN HUMAN AND RAT MICROSOMES AND RECOMBINANT UDP-GLUCURONOSYLTRANSFERASE ISOFORMS
      Melanie N. Tallman, Joseph K. Ritter and Philip C. Smith
      Drug Metabolism and Disposition July 2005, 33 (7) 977-983; DOI: https://doi.org/10.1124/dmd.104.003491
  15. Sohr, Reinhard

    1. You have access
      SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA
      Jens Teichert, Reinhard Sohr, Frank Baumann, Lothar Hennig, Karlheinz Merkle, Karel Caca and Rainer Preiss
      Drug Metabolism and Disposition July 2005, 33 (7) 984-992; DOI: https://doi.org/10.1124/dmd.105.003624
  16. Sparidans, Rolf W.

    1. You have access
      MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4
      Antonius E. van Herwaarden, Johan W. Smit, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition July 2005, 33 (7) 892-895; DOI: https://doi.org/10.1124/dmd.105.004721
  17. St. Peter, J. V.

    1. You have access
      MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234
  18. Stewart, S.

    1. You have access
      MONOCLONAL NICOTINE-SPECIFIC ANTIBODIES REDUCE NICOTINE DISTRIBUTION TO BRAIN IN RATS: DOSE- AND AFFINITY-RESPONSE RELATIONSHIPS
      D. E. Keyler, S. A. Roiko, E. Benlhabib, M. G. LeSage, J. V. St. Peter, S. Stewart, S. Fuller, C. T. Le and P. R. Pentel
      Drug Metabolism and Disposition July 2005, 33 (7) 1056-1061; DOI: https://doi.org/10.1124/dmd.105.004234
  19. Strom, Stephen C.

    1. You have access
      ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954
  20. Subramanian, Raju

    1. You have access
      INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITY
      Christopher R. Gibson, Charles Lin, Rominder Singh, Cheri M. Brown, Karen Richards, Janice Brunner, Kimberly Michel, Jennifer Adelsberger, Edward Carlini, Catherine Boothe-Genthe, Conrad Raab, Minh Luu, Aimee Michael, Mona Parikh, Patrice Ciecko, Raju Subramanian, Paul Krolikowski, A. David Rodrigues, Thomas A. Baillie and Thomas H. Rushmore
      Drug Metabolism and Disposition July 2005, 33 (7) 1044-1051; DOI: https://doi.org/10.1124/dmd.105.003913
  21. Sugiyama, Yuichi

    1. You have access
      REGULATION OF THE CELL SURFACE EXPRESSION OF HUMAN BCRP/ABCG2 BY THE PHOSPHORYLATION STATE OF AKT IN POLARIZED CELLS
      Tappei Takada, Hiroshi Suzuki, Yukiko Gotoh and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2005, 33 (7) 905-909; DOI: https://doi.org/10.1124/dmd.104.003228
    2. You have access
      P-GLYCOPROTEIN PLAYS A MAJOR ROLE IN THE EFFLUX OF FEXOFENADINE IN THE SMALL INTESTINE AND BLOOD-BRAIN BARRIER, BUT ONLY A LIMITED ROLE IN ITS BILIARY EXCRETION
      Harunobu Tahara, Hiroyuki Kusuhara, Eiichi Fuse and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2005, 33 (7) 963-968; DOI: https://doi.org/10.1124/dmd.105.004192
  22. Suzuki, Hiroshi

    1. You have access
      REGULATION OF THE CELL SURFACE EXPRESSION OF HUMAN BCRP/ABCG2 BY THE PHOSPHORYLATION STATE OF AKT IN POLARIZED CELLS
      Tappei Takada, Hiroshi Suzuki, Yukiko Gotoh and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2005, 33 (7) 905-909; DOI: https://doi.org/10.1124/dmd.104.003228

T

  1. Tahara, Harunobu

    1. You have access
      P-GLYCOPROTEIN PLAYS A MAJOR ROLE IN THE EFFLUX OF FEXOFENADINE IN THE SMALL INTESTINE AND BLOOD-BRAIN BARRIER, BUT ONLY A LIMITED ROLE IN ITS BILIARY EXCRETION
      Harunobu Tahara, Hiroyuki Kusuhara, Eiichi Fuse and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2005, 33 (7) 963-968; DOI: https://doi.org/10.1124/dmd.105.004192
  2. Takada, Tappei

    1. You have access
      REGULATION OF THE CELL SURFACE EXPRESSION OF HUMAN BCRP/ABCG2 BY THE PHOSPHORYLATION STATE OF AKT IN POLARIZED CELLS
      Tappei Takada, Hiroshi Suzuki, Yukiko Gotoh and Yuichi Sugiyama
      Drug Metabolism and Disposition July 2005, 33 (7) 905-909; DOI: https://doi.org/10.1124/dmd.104.003228
  3. Tallman, Melanie N.

    1. You have access
      DIFFERENTIAL RATES OF GLUCURONIDATION FOR 7-ETHYL-10-HYDROXY-CAMPTOTHECIN (SN-38) LACTONE AND CARBOXYLATE IN HUMAN AND RAT MICROSOMES AND RECOMBINANT UDP-GLUCURONOSYLTRANSFERASE ISOFORMS
      Melanie N. Tallman, Joseph K. Ritter and Philip C. Smith
      Drug Metabolism and Disposition July 2005, 33 (7) 977-983; DOI: https://doi.org/10.1124/dmd.104.003491
  4. Tang, Zhongming

    1. You have access
      METABOLIC PROFILE OF 1,5-DICAFFEOYLQUINIC ACID IN RATS, AN IN VIVO AND IN VITRO STUDY
      Bo Yang, Zhiyun Meng, Junxing Dong, Liangping Yan, Libo Zou, Zhongming Tang and Guifang Dou
      Drug Metabolism and Disposition July 2005, 33 (7) 930-936; DOI: https://doi.org/10.1124/dmd.104.002154
  5. Taskinen, Jyrki

    1. You have access
      KINETIC CHARACTERIZATION OF THE 1A SUBFAMILY OF RECOMBINANT HUMAN UDP-GLUCURONOSYLTRANSFERASES
      Leena Luukkanen, Jyrki Taskinen, Mika Kurkela, Risto Kostiainen, Jouni Hirvonen and Moshe Finel
      Drug Metabolism and Disposition July 2005, 33 (7) 1017-1026; DOI: https://doi.org/10.1124/dmd.105.004093
  6. Teichert, Jens

    1. You have access
      SYNTHESIS AND CHARACTERIZATION OF SOME NEW PHASE II METABOLITES OF THE ALKYLATOR BENDAMUSTINE AND THEIR IDENTIFICATION IN HUMAN BILE, URINE, AND PLASMA FROM PATIENTS WITH CHOLANGIOCARCINOMA
      Jens Teichert, Reinhard Sohr, Frank Baumann, Lothar Hennig, Karlheinz Merkle, Karel Caca and Rainer Preiss
      Drug Metabolism and Disposition July 2005, 33 (7) 984-992; DOI: https://doi.org/10.1124/dmd.105.003624
  7. Thummel, Kenneth E.

    1. You have access
      CONTRIBUTION OF CYP3A5 TO HEPATIC AND RENAL IFOSFAMIDE N-DECHLOROETHYLATION
      Jeannine S. McCune, Linda J. Risler, Brian R. Phillips, Kenneth E. Thummel, David Blough and Danny D. Shen
      Drug Metabolism and Disposition July 2005, 33 (7) 1074-1081; DOI: https://doi.org/10.1124/dmd.104.002279
  8. Trask, Heidi W.

    1. You have access
      ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954

U

  1. Unadkat, Jashvant D.

    1. You have access
      IDENTIFICATION OF CYTOCHROME P450 AND ARYLAMINE N-ACETYLTRANSFERASE ISOFORMS INVOLVED IN SULFADIAZINE METABOLISM
      Helen R. Winter and Jashvant D. Unadkat
      Drug Metabolism and Disposition July 2005, 33 (7) 969-976; DOI: https://doi.org/10.1124/dmd.104.002998

V

  1. van der Kruijssen, Cornelia M. M.

    1. You have access
      MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4
      Antonius E. van Herwaarden, Johan W. Smit, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition July 2005, 33 (7) 892-895; DOI: https://doi.org/10.1124/dmd.105.004721
  2. van Herwaarden, Antonius E.

    1. You have access
      MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4
      Antonius E. van Herwaarden, Johan W. Smit, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition July 2005, 33 (7) 892-895; DOI: https://doi.org/10.1124/dmd.105.004721
  3. Van Houdt, Jos

    1. You have access
      EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046
  4. Van Looveren, Cis

    1. You have access
      EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046

W

  1. Wagenaar, Els

    1. You have access
      MIDAZOLAM AND CYCLOSPORIN A METABOLISM IN TRANSGENIC MICE WITH LIVER-SPECIFIC EXPRESSION OF HUMAN CYP3A4
      Antonius E. van Herwaarden, Johan W. Smit, Rolf W. Sparidans, Els Wagenaar, Cornelia M. M. van der Kruijssen, Jan H. M. Schellens, Jos H. Beijnen and Alfred H. Schinkel
      Drug Metabolism and Disposition July 2005, 33 (7) 892-895; DOI: https://doi.org/10.1124/dmd.105.004721
  2. Wahlstrom, Jan L.

    1. You have access
      THREE-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP ANALYSIS OF CYTOCHROMES P450: EFFECT OF INCORPORATING HIGHER-AFFINITY LIGANDS AND POTENTIAL NEW APPLICATIONS
      Charles W. Locuson and Jan L. Wahlstrom
      Drug Metabolism and Disposition July 2005, 33 (7) 873-878; DOI: https://doi.org/10.1124/dmd.105.004325
  3. Ward, Brian J.

    1. You have access
      CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS
      Jean-Nicholas Roy, Julie Lajoie, Lynn S. Zijenah, Azemi Barama, Charles Poirier, Brian J. Ward and Michel Roger
      Drug Metabolism and Disposition July 2005, 33 (7) 884-887; DOI: https://doi.org/10.1124/dmd.105.003822
  4. Weygers, Adri

    1. You have access
      EXPRESSION AND INDUCTION POTENTIAL OF CYTOCHROMES P450 IN HUMAN CRYOPRESERVED HEPATOCYTES
      Dirk Roymans, Pieter Annaert, Jos Van Houdt, Adri Weygers, Jan Noukens, Carlo Sensenhauser, José Silva, Cis Van Looveren, Jan Hendrickx, Geert Mannens and Willem Meuldermans
      Drug Metabolism and Disposition July 2005, 33 (7) 1004-1016; DOI: https://doi.org/10.1124/dmd.104.003046
  5. Winter, Helen R.

    1. You have access
      IDENTIFICATION OF CYTOCHROME P450 AND ARYLAMINE N-ACETYLTRANSFERASE ISOFORMS INVOLVED IN SULFADIAZINE METABOLISM
      Helen R. Winter and Jashvant D. Unadkat
      Drug Metabolism and Disposition July 2005, 33 (7) 969-976; DOI: https://doi.org/10.1124/dmd.104.002998
  6. Wood, Sheryl G.

    1. You have access
      ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954
  7. Wrighton, Steven A.

    1. You have access
      THE USE OF A SUBSTRATE CASSETTE STRATEGY TO IMPROVE THE CAPACITY AND THROUGHPUT OF CYTOCHROME P450 INDUCTION STUDIES IN HUMAN HEPATOCYTES
      Michael A. Mohutsky, David M. Petullo and Steven A. Wrighton
      Drug Metabolism and Disposition July 2005, 33 (7) 920-923; DOI: https://doi.org/10.1124/dmd.105.004291
    2. You have access
      ARSENITE DECREASES CYP3A4 AND RXRα IN PRIMARY HUMAN HEPATOCYTES
      Trisha L. Noreault, Vsevolod E. Kostrubsky, Sheryl G. Wood, Ralph C. Nichols, Stephen C. Strom, Heidi W. Trask, Steven A. Wrighton, Ronald M. Evans, Judith M. Jacobs, Peter R. Sinclair and Jacqueline F. Sinclair
      Drug Metabolism and Disposition July 2005, 33 (7) 993-1003; DOI: https://doi.org/10.1124/dmd.105.003954

Y

  1. Yamanaka, Yosuke

    1. You have access
      IDENTIFICATION OF HMG-CoA REDUCTASE INHIBITORS AS ACTIVATORS FOR HUMAN, MOUSE AND RAT CONSTITUTIVE ANDROSTANE RECEPTOR
      Kaoru Kobayashi, Yosuke Yamanaka, Norihiko Iwazaki, Ikumi Nakajo, Masakiyo Hosokawa, Masahiko Negishi and Kan Chiba
      Drug Metabolism and Disposition July 2005, 33 (7) 924-929; DOI: https://doi.org/10.1124/dmd.104.002741
  2. Yan, Liangping

    1. You have access
      METABOLIC PROFILE OF 1,5-DICAFFEOYLQUINIC ACID IN RATS, AN IN VIVO AND IN VITRO STUDY
      Bo Yang, Zhiyun Meng, Junxing Dong, Liangping Yan, Libo Zou, Zhongming Tang and Guifang Dou
      Drug Metabolism and Disposition July 2005, 33 (7) 930-936; DOI: https://doi.org/10.1124/dmd.104.002154
  3. Yang, Bo

    1. You have access
      METABOLIC PROFILE OF 1,5-DICAFFEOYLQUINIC ACID IN RATS, AN IN VIVO AND IN VITRO STUDY
      Bo Yang, Zhiyun Meng, Junxing Dong, Liangping Yan, Libo Zou, Zhongming Tang and Guifang Dou
      Drug Metabolism and Disposition July 2005, 33 (7) 930-936; DOI: https://doi.org/10.1124/dmd.104.002154

Z

  1. Zijenah, Lynn S.

    1. You have access
      CYP3A5 GENETIC POLYMORPHISMS IN DIFFERENT ETHNIC POPULATIONS
      Jean-Nicholas Roy, Julie Lajoie, Lynn S. Zijenah, Azemi Barama, Charles Poirier, Brian J. Ward and Michel Roger
      Drug Metabolism and Disposition July 2005, 33 (7) 884-887; DOI: https://doi.org/10.1124/dmd.105.003822
  2. Zou, Libo

    1. You have access
      METABOLIC PROFILE OF 1,5-DICAFFEOYLQUINIC ACID IN RATS, AN IN VIVO AND IN VITRO STUDY
      Bo Yang, Zhiyun Meng, Junxing Dong, Liangping Yan, Libo Zou, Zhongming Tang and Guifang Dou
      Drug Metabolism and Disposition July 2005, 33 (7) 930-936; DOI: https://doi.org/10.1124/dmd.104.002154
Back to top
PreviousNext

In this issue

Drug Metabolism and Disposition: 33 (7)
Drug Metabolism and Disposition
Vol. 33, Issue 7
1 Jul 2005
  • Table of Contents
  • About the Cover
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Cytochrome P450 inhibitors. Evaluation of specificities in the in vitrometabolism of therapeutic agents by human liver microsomes.
  • Prediction of Human Clearance of Twenty-Nine Drugs from Hepatic Microsomal Intrinsic Clearance Data: An Examination of In Vitro Half-Life Approach and Nonspecific Binding to Microsomes
  • DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS
  • In Vitro-In Vivo Scaling of CYP Kinetic Data Not Consistent with the Classical Michaelis-Menten Model
  • THE HUMAN INTESTINAL CYTOCHROME P450 “PIE”
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About DMD
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Journal of Pharmacology and Experimental Therapeutics
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-009X (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics